Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

September is recognized as Ovarian Cancer Awareness Month. But, do you know the signs and symptoms that could be impacting ...

Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Southern District of Texas ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

Research has found 78% of women in the UK do not know the signs and symptoms of the five gynaecological cancers.

J&J's Red River Talc unit made its filing in the U.S. Bankruptcy Court for the Southern District of Texas. J&J faces lawsuits ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Johnson & Johnson said it received overwhelming support for a roughly $8 billion settlement of claims that its talc-based ...

GILSON, Angela Thomas, 55, passed peacefully on September 15, 2024 surrounded by the love of her family after a two-year battle with ovarian cancer. Angie was born in Roanoke, Virginia, on March 26, ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...